SolventumSOLV
Market Cap: $11.4B
About: Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Employees: 22,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
4,268% more first-time investments, than exits
New positions opened: 830 | Existing positions closed: 19
3,551% more capital invested
Capital invested by funds: $152M [Q1] → $5.55B (+$5.4B) [Q2]
1,248% more funds holding
Funds holding: 65 [Q1] → 876 (+811) [Q2]
200% more funds holding in top 10
Funds holding in top 10: 3 [Q1] → 9 (+6) [Q2]
145% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 11
117% more call options, than puts
Call options by funds: $48.8M | Put options by funds: $22.5M
60.81% more ownership
Funds ownership: 0% [Q1] → 60.81% (+60.81%) [Q2]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Goldman Sachs David Roman 50% 1-year accuracy 5 / 10 met price target | 18%downside $54 | Sell Maintained | 12 Aug 2024 |
Wells Fargo Vik Chopra 20% 1-year accuracy 1 / 5 met price target | 3%downside $64 | Equal-Weight Maintained | 9 Aug 2024 |
Morgan Stanley Patrick Wood 69% 1-year accuracy 9 / 13 met price target | 17%downside $55 | Equal-Weight Maintained | 15 Jul 2024 |
Goldman Sachs David Roman 50% 1-year accuracy 5 / 10 met price target | 27%downside $48 | Sell Maintained | 10 Jul 2024 |
B of A Securities Travis Steed 75% 1-year accuracy 3 / 4 met price target | 9%downside $60 | Neutral Maintained | 25 Jun 2024 |
Financial journalist opinion
Based on 7 articles about SOLV published over the past 30 days